The Massachusetts Institute of Technology is suing Dharmacon for failing to pay sufficient royalties on the sale of its RNAi products, according to court documents obtained by RNAi News.
According to MIT’s lawsuit filed in the US District Court for the District of Massachusetts, the research institute in December 2001 granted Dharmacon co-exclusive rights to use its siRNA technology for internal research or to sell research reagents based on the technology for educational and research purposes.